BLI Stock Price, News & Analysis
Company Description
BLI (NASDAQ: bli) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $86.6M.
bli stock has declined 83.0% over the past year.
This page provides a comprehensive overview of bli stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BLI (bli) stock. Over the past 12 months, the stock has lost 83.0%. At a market capitalization of $86.6M, bli is classified as a micro-cap stock with approximately 72.2M shares outstanding.
Latest News
BLI has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include acquisition, conferences, earnings, management. View all bli news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
bli Company Profile & Sector Positioning
BLI (bli) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing bli often look at related companies in the same sector, including Nautilus Biotechnology Inc (NAUT), Champions Oncolo (CSBR), Atara Biotherape (ATRA), Nutriband Inc (NTRB), and Immunoprecise (IPA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate bli's relative position within its industry.